Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture

NCT07086872 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07086872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 30, 2025
Completion date
February 20, 2026
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

forward head posture